Clinical significance of low serum isoniazid level among the patients with drug-sensitive pulmonary tuberculosis who showed delayed smear or culture conversion.
J. Kim (Incheon, Republic of Korea), Y. Kim (Bucheon, Republic of Korea), J. Kim (Uijeongbu, Republic of Korea), J. Hah (Incheon, Republic of Korea), A. Shin (Incheon, Republic of Korea), H. Kim (Incheon, Republic of Korea), J. Ahn (Incheon, Republic of Korea)
Source: International Congress 2018 – New developments in tuberculosis
Session: New developments in tuberculosis
Session type: Oral Presentation
Number: 1959
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Kim (Incheon, Republic of Korea), Y. Kim (Bucheon, Republic of Korea), J. Kim (Uijeongbu, Republic of Korea), J. Hah (Incheon, Republic of Korea), A. Shin (Incheon, Republic of Korea), H. Kim (Incheon, Republic of Korea), J. Ahn (Incheon, Republic of Korea). Clinical significance of low serum isoniazid level among the patients with drug-sensitive pulmonary tuberculosis who showed delayed smear or culture conversion.. 1959
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Comparison of serum CA-125 levels in pulmonary tuberculosis, pleural tuberculosis and treated active pulmonary tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 453s Year: 2005
Detection of isoniazid or rifampin resistant Mycobacterium tuberculosis in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005
Value of bronchoscopic specimens for the diagnosis of sputum smear negative tuberculosis in high burden multidrug resistant tuberculosis setting Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions Year: 2012
To determine the acquired resistance of mycobacterium tuberculosis by culture to 1st line anti-tuberculous drugs in non responding smear positive patients who have taken category 1 Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011
Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis Source: Eur Respir J 2011; 37: 376 Year: 2011
Isoniazid resistance is associated with delayed culture conversion during anti-tuberculosis treatment among patients with pulmonary tuberculosis Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018
Decreasing level of serum ADA: A valuable predictor of treatment in smear positive tuberculosis Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011
Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 164s Year: 2006
Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012
The significance of smear result at two month in pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 586s Year: 2006
Predictors of delayed sputum culture conversion in tuberculosis patients Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011
The relationship between extension of disease in the patients with smear positive pulmonary tuberculosis and hepatotoxicity Source: Eur Respir J 2006; 28: Suppl. 50, 6s Year: 2006
Clinical characteristic of the patients with drug resistant pulmonary tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 661s Year: 2007
Pitfalls in the registration and delay in the treatment of patients with culture positive pulmonary tuberculosis (CPPTB) Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007
The significance of smear result at two months in pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 368s Year: 2002
Direct molecular testing for isoniazid and rifampicin resistance from respiratory specimens of patients with tuberculosis Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013
The choice of 4th drug in treatment of cavitary smear positive pulmonary tuberculosis: streptomycine versus ethambutol Source: Eur Respir J 2005; 26: Suppl. 49, 645s Year: 2005
Factors that affect sputum smear and culture conversion in patients with smear positive pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 428s Year: 2005
High serum CA-125 level in active pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 415s Year: 2005
The rate of tuberculosis infection in closed contacts of smear positive pulmonary tuberculosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 474s Year: 2002